Loyal
Extending the lifespan of dogs.
Backed by
Raised $22M Series B on Feb 26, 2025
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.
Explore similar companies to Loyal
Invert
Modern software for bioprocess data.
Sway
Seaweed as replacement for plastic.
Convoke
AI-native OS for drug development.
Science
A brighter tomorrow enabled by neural engineering.
Salt
AI for life sciences.
Chai Discovery
Engineering better molecules using artificial intelligence.
Cortical Labs
Lab-grown neurons with silicon chips.
Cradle
Design better proteins.
Manifold Bio
Tissue-targeted medicines, designed in vivo.